NCT00077207View on ClinicalTrials.gov

Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

March 31, 2010

Study Completion Date

December 31, 2013

Conditions
Brain TumorCentral Nervous System Tumor
Interventions
DRUG

carboplatin

Given IV

DRUG

temozolomide

Given orally

DRUG

vincristine sulfate

Given IV

Trial Locations (1)

19104

Childrens Oncology Group, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Oncology Group

NETWORK

NCT00077207 - Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma | Biotech Hunter | Biotech Hunter